Chemical mapping methods probe RNA structure by revealing and leveraging correlations of a nucleotide's structural accessibility or flexibility with its reactivity to various chemical probes. Pioneering work by Lucks and colleagues has expanded this method to probe hundreds of molecules at once on an Illumina sequencing platform, obviating the use of slab gels or capillary electrophoresis on one molecule at a time. Here, we describe optimizations to this method from our lab, resulting in the MAP-seq protocol (Multiplexed Accessibility Probing read out through sequencing), version 1.0. The protocol permits the quantitative probing of thousands of RNAs at once, by several chemical modification reagents, on the time scale of a day using a table-top Illumina machine. This method and a software package MAPseeker (http://simtk.org/home/map_seeker) address several potential sources of bias, by eliminating PCR steps, improving ligation efficiencies of ssDNA adapters, and avoiding problematic heuristics in prior algorithms. We hope that the step-by-step description of MAP-seq 1.0 will help other RNA mapping laboratories to transition from electrophoretic to next-generation sequencing methods and to further reduce the turnaround time and any remaining biases of the protocol.
Introduction
RNAs play an active role in all kingdoms of life (1, 2), with known functions including catalysis (2, 3) , gene regulation (4), genome maintenance (5) , and protein synthesis (1). The functions of RNA molecules appear to be critically dependent on their structures or, in the case of gene translation, their lack of structure. Comparative sequence analysis, x-ray crystallography, and NMR (6, 7) remain the gold standards for inferring functional secondary structures and tertiary interactions in RNA molecules. However, all three of these tools require significant investigator insight and effort and are not generally tractable for all RNAs. When these methods have not been applicable, chemical probing has been a valuable tool, particularly to falsify or support preexisting structural models (8) (9) (10) . Enhancing the information content of chemical probing to permit de novo structure determination, to leverage novel chemical probes, and to accelerate RNA design are ongoing areas of research (11) (12) (13) (14) (15) . Most chemical probes tend to react with nucleotides that are solvent-exposed, flexible, or otherwise uninvolved in canonical or noncanonical base pairing (16) (17) (18) (19) (20) (21) (22) . These reactivities are often read out via a reverse transcriptase reaction that extends a DNA primer complementary to the modified RNA (16) (17) (18) (19) (20) (21) (22) . The reverse transcriptase stops at the site of a modification, leaving a complementary DNA (cDNA) whose length marks the modified nucleotide. To identify the sites of the reactive nucleotides, the pool of cDNAs is typically analyzed through length separation by gel or capillary electrophoresis (CE), using radiolabeled or fluorophore-labeled primers, respectively.
With magnetic bead purifications and 96-well plates, mapping several dozen RNAs with a set of different chemical reagents is now feasible on the time scale of a day (see Chapter on the Mutate-and-Map method, in this volume). However, some applications, such as characterizing RNAs discovered by high-throughput biological screens or created by computational design (13) , require probing 1000s of RNAs. Enzymatic mapping, which gives sparse reads, can be carried out on such large pools-or, indeed, at a genome-wide scale (23-25)-through next-generationsequencing, but these data do not carry the information content of single-nucleotide-resolution chemical probes. An experimental protocol and bioinformatics pipeline developed by Lucks and colleagues has pioneered the use of 2´-OH acylating reagents and Illumina next-generation sequencing (NGS) to enable highly parallel chemical mapping of several RNAs (26, 27), but the method has not yet been applied to RNAs of many distinct sequences or with alternative chemical probes (26). Furthermore, in our hands, this method leads to mapping profiles that do not agree within error with measurements from replicate mapping experiments based on capillary electrophoresis. The differences are at least partially due to the sequence-dependence of ligation and amplification steps that have been used to prepare libraries for Illumina sequencing (unpublished data).
To increase the rate at which a large number of RNAs may be probed and to reduce bias, we have further advanced this protocol into a MAP-seq (Multiplexed Accessibility Probing) method ( Figure 1 ). Multiple chemical reactions, such as DMS alkylation (12) , carbodiimide modification of bases (12, 28) and acylation of the 2´-hydroxyl (21, 22) can be carried out in parallel ( Figure 2 ). Addition of an Illumina adapter sequence to reverse transcribed DNA is carried out under conditions that give near-quantitative single stranded DNA ligation (29, 30) . Unique sequence identifiers at the 3´ ends of each the RNA are sequestered into hairpins ( Figure  1 , Table 1 ) to help prevent interference with the fold of the RNA segment of interest. Solution PCR steps, which can introduce significant length and sequence bias, are eliminated. Last, we noticed that current NGS sequence analysis packages (31-33) either became unusably slow and/or inaccurate in assigning reads at the 3´ ends of sequences and across highly similar sequences (e.g., single mutants in mutate-and-map experiments). We have therefore developed a new automated tool, called MAPseeker, which quantifies the reactivities of the nucleotides of each RNA under each condition.
Comparisons of this NGS approach and prior CE methods are shown for different chemical modifiers in Figure 2 . The data from the two techniques agree within the estimated error of each method, as can be seen in direct overlays for two RNAs (Figure 3 ). These data suggest that MAP-seq biases have been reduced to the point that the NGS-based data are as trustworthy as CE data.
The MAP-seq protocol is rapidly evolving, with active developments to enhance multiplexing through "index" reads in Illumina machines, to probe oligonucleotide pools and sub-pools derived from massively parallel synthesis technologies, and to tackle RNAs with lengths of kilobases. Continuing improvements in single-stranded DNA ligation, through new enzymes and solution conditions (34, 35), may further reduce any residual bias at this step. This chapter gives a snapshot of our stable "version 1.0" lab protocol that runs on the table-top MiSeq platform for RNA pools with lengths up to 200 nucleotides.
Materials

General Materials
The protocol given below assumes that four chemical probes will be tested on the pool of RNAs: no modification (addition of water or DMSO), DMS, CMCT, and 1M7. We carry out some steps of this procedure within wells of a 96-well plate, which enables use of magnetic separators and multichannel pipetters and can reduce the experimentalist's effort. Alternatively, the entire protocol can also be carried out in RNAse-free non-stick Eppendorf tubes. We use a capillary electrophoresis (CE) sequencer and fluorescent primers to check the yield and length distribution at two steps prior to Illumina sequencing. Use of fluorescent DNA is particularly convenient for rapidly piloting improvements to the protocol and for directly comparing CE data to Illumina data. As an alternative, steps to monitor the lengths of DNA fragments can also be carried out without fluorescent primers on, e.g., Agilent Bioanalyzer systems (26). starting the chemical mapping part of this protocol. If these types of incubators are not available, a water bath or thermocycler may be substituted. 9. Access to an ABI 3100 sequencer or similar equipment for capillary electrophoresis.
Chemical Modification of RNA
It is assumed that the investigator has already obtained the RNA molecules of interest, either by chemical synthesis, in vitro transcription, or extraction from cells or viruses. The protocol below has been tested most thoroughly on pools of RNAs that have identical primer binding sites (PBS) at their 3´ ends. In addition, it is critical that the last segment of each sequence (RID in Figure 1 ), immediately 5´ to the reverse transcription binding site, be unique in the pool (26, 27). These nucleotides (8 in our example cases below; see Table 1 ) are used later to identify the RNA with which each NGS read is associated. In our examples, these 8 nucleotides are arbitrary octamers, but we also included additional complementary nucleotides to sequester the RID into a hairpin capped by a UUCG tetraloop (Table 1) , which reduces the potential for this added sequence interfering with the RNA fold. Aside from these PBS and RID segments, there are few other constraints. We have carried out MAP-seq on RNA pools with between one and 4000 distinct sequences in a single experiment. Different chemical modification reagents probe different nucleotides and different aspects of the RNA structure. Each reagent may need its own quench. We list the recipes for most common modification reagents and their quenches at concentrations and reaction times appropriate for RNAs under 100 nucleotides in length. Longer RNAs should use lower concentrations and/or shorter reaction times. When deviating from these conditions or using alternative reagents, the RNA molecules should be modified with single-hit frequency, which may depend on reagent concentration, reaction time, and temperature. The protocol given below assumes that four chemical probes will be tested on the pool of RNAs: no modification (addition of water or DMSO), DMS, CMCT, and 1M7. Every 4-sample reaction will require the following:
1. Each reaction should use 2.5 to 5.0 pmol of total RNA (5 μL of 0.5-1.0 μM RNA). 2. 10.0 µL of 0.5 M Na-HEPES, pH 8.0 (from a sterile stock filtered with a 0.2 µm filter).
Other pH stocks can be used, but note that carbodiimide and 2´-hydroxyl modification reactions, as well as other modifers, are sensitive to pH. 3. 20 µL of 50 mM MgCl 2 if the RNA requires magnesium for proper folding. If not, 20 µL 5 M NaCl can be used to give 1 M NaCl conditions; or other folding buffer. 4. 280 μL Agencort AMPure XP (Beckman Coulter) for RNA purification. (See Note 1 and Note 2). 5. DMS mix for dimethyl sulfate mapping, which attacks exposed Watson-Crick faces of adenines and cytosines in RNA and DNA: Mix 1.0 µL fresh dimethyl sulfate (Sigma) into 9.0 µL 100% ethanol, then add 90.0 µL of sterile water. The quench for this reaction is 2-mercaptoethanol (Sigma). Each DMS reaction needs 5 μL DMS mix. 6. CMCT mix for carbodiimide mapping using 1-cyclohexyl-(2morpholinoethyl)carbodiimide metho-p-toluene sulfonate (CMCT), which attacks exposed Watson-Crick faces of guanines and uracils in RNA: Mix 42 mg/ml of CMCT in H 2 O. The solid stock for reagent is usually kept at -20 ° C. Before mixing into water, incubate it at room temperature for 15 minutes, immediately prior to experiment. The quench for this reaction is 0.4 M Na-MES, pH 6.0. Each CMCT reaction needs 5 μL CMCT mix. 7. 1M7 mix for 2´-hydroxyl acylation mapping using 1-methyl-7-nitroisatoic anhydride (1M7), a fast-acting reagent which attacks dynamic nucleotides by modifying the 2´ hydroxyl of an RNA: Mix 10 mg of 1M7 into 1 mL anhydrous DMSO. The quench for this reaction is 2-mercaptoethanol (Sigma). Each 1M7 reaction needs 5 μL 1M7 mix. An alternative reagent for 2´-hydroxyl acylation is N-methylisatoic anhydride (NMIA). . 0.5 μL each of at least four 1 μM reverse transcription primers per sample. These primers contain the Illumina adapter for bridge amplification at the 5´ ends, followed by the Illumina sequencing primer binding sequence, followed by a primer identifier sequence (PID; see Figure 1 ), and finished with a region to bind the conserved 3´ ends of the RNAs. The PID region is 12 nucleotides long and must be sequence-balanced as part of a set of four primers (See Note 3 and Table 1 ). The different PIDs can be used to distinguish between the same RNA modified by different reagents or subject to different modification reaction conditions. The primers should be purified by polyacrylamide gel electrophoresis (PAGE) or HPLC. 
Reverse Transcription
Final Preparation for Sequencing
For every 4-sample reaction, you will need 1. 0.5 μL 10 nM PhiX genomic DNA (20 nM of single strands), prepared for sequencing (Illumina, see Note 9). 2. 2 μL 2.0 N NaOH (Illumina, or other supplier) 3. 10.0 μL EB buffer (Qiagen)
Methods
All steps are at room temperature unless specified.
Chemical Modification
1. Prepare modification buffer at 2x concentration. For each 20 μL reaction, mix 2 μL 0.5 M Na-HEPES, pH 8.0, 4 μL appropriate salt solution (e.g., either 50 mM MgCl 2 or 5 M NaCl, as above), and 4 μL RNase-free H 2 O. For four reactions, prepare enough premix for five reactions (e.g., 10 μL 0.5 M Na-HEPES, pH 8.0; 20 μL of 50 mM MgCl 2 ; and 20 μL RNase-free H 2 O). 2. Add 5 μL of each RNA solution to as many samples in the 96-well plates as you have reagents and reaction conditions. Add 10 μL of modification buffer to each well. Seal the plate with sealer tape. Let the RNAs fold at room temperature for 20 minutes, or, if necessary, place into a thermocycler, and take the plate through the necessary temperature steps to ensure proper folding of the RNA or RNAs in question. 3. While the RNA is folding, prepare fresh stocks of modification reagents as above.
Always make sure that one of the modification conditions is just H 2 O or just anhydrous DMSO, as a control reading for background reverse transcriptase stops. Array the various modification reagents in the auxiliary plate so that they may be easily added to the main reaction plate. 4. Add 5 μL of the modification reagent to each corresponding well of the main reaction plate. For four modification conditions [(A) no modification, (B) DMS, (C) CMCT, and (D) 1M7], use 5 μL of each stock reagents freshly prepared as above. The total volume in each of four reactions is now 20 μL. 5. Seal the plate and let incubate. For RNAs under 100 nucleotides with the modification reagents listed above, 30 minutes is appropriate. For longer RNAs, less time may be necessary so as to achieve single-hit kinetics. Alternative reagents may require their own modifications to this protocol (See Note 5). 6. While the RNAs are incubating with the modification reagents, array the quenches in corresponding locations in the auxiliary plate (or in a new auxiliary plate) so that they may be easily added to the main reaction plate. After the appropriate incubation time, add 20 μL of the corresponding quench to each well. The volume of each sample is now 40 μL. 7. Prepare the bead purification mix: for each reaction well: mix 70 μL AMPure XP beads with 30 μL 40% polyethylene glycol 8000. Pipette up and down at least 10 times to mix. Add 100 μL bead purification mix (2.5x volumes) to each reaction. Again pipette up and down at least 10 times to mix. Wait 10 minutes for the beads to bind the RNA (See Note 2). 8. Set the plate on a 24-post magnetic stand and wait 5 minutes for the beads to collect near magnets. 9. Pipette off the supernatant and discard. 10. Rinse the beads with 100 μL 70% ethanol. Shake briefly with the plate on the stand(s).
Wait 30 seconds. Remove the 70% ethanol supernatant 11. Repeat step 10. This time, take extra care to remove the last traces of the 70% ethanol supernatant with a P10 pipette (See Note 6). 12. Let the samples dry for 10 minutes while remaining on the magnetic stand. Remove any final visible droplets of 70% ethanol with a P10 pipette. 13. Resuspend the beads in each well in 2.5 μL RNase-free H 2 O.Take the plate off the magnetic stand(s). Let stand for 5 minutes to ensure release of RNAs. 14. Place the plate back on the magnetic stand(s). Wait 1-2 minutes for the beads to collect.
Transfer the supernatant in each well, which now contain the released, modified RNA, to a new plate.
Reverse Transcription
1. Prepare fresh primer stocks (See Note 4), 1 μM each. Primers should be used in sets of 4, which will be referred to as A-D within one set-primer A for the first reaction in a set of four, primer B for the second, etc. All primers in a set need to be used, due to sequence balancing requirements of the Illumina platform (See Note 3, Table 1 for example sequences). For at least one primer (primer A in this example), however, instead of using pure unlabeled primer, prepare a mixture from equal parts 1 μM unlabeled primer A and 1 μM fluorescently-labeled primer A to use as the primer for the reaction in a group of four. This fluorescent tracer will allow for a rapid quality check by standard capillary sequencing prior to running on the Illumina sequencer. It is also fine to use pure fluorescently labeled primer A, or to label all primers in use. The fluorophore labeled cDNA does not interfere with the Illumina sequencing protocol (it is washed away during the bridge PCR on the Illumina flow cell). RNAs, longer incubation times may be used to help complete reverse transcription. 6. After 30 min, hydrolyze the leftover RNA by adding 5 µL of 0.4 M NaOH to each well.
Incubate the plate at 90 ºC for 3 minutes. 7. Add 5 µL of the acid quench mix (see recipe in Reverse Transcription materials section) to each well. Let the plate cool on ice for 5 minutes. 8. Add 4 µL of the Oligo C´ beads (see recipe in Reverse Transcription materials section) to each well. Mix thoroughly by pipetting up and down at least 10 times. Incubate at room temperature 10 minutes to ensure cDNA binding to the beads. 9. Place the plate on a magnetic stand and wait 1-5 minutes for the beads to collect. 10 Transfer the supernatant to an optical plate used by an ABI capillary electrophoresis sequencer. These samples can be loaded on an ABI sequencer to ensure reverse transcription worked properly before proceeding to the ligation step (see below); alternatively they can be loaded at the same time as the ligated samples to save effort. 17. The remaining samples (still with beads) may be pooled for convenience before proceeding. Ensure the beads are still well-suspended in water by pipetting up and down.
In the example case with one pool of RNAs modified under 4 conditions, the total volume of the combined samples will be 8 μL. foldername_with_ABI_data corresponds to the path of the folder containing the data from the quality check immediately after reverse transcription, and the quality check after ligation. The numbers lowerbound and upperbound depend on the length of the RNA(s) in question. In the resulting view of the capillary traces, ensure that bands are visible for the reverse transcribed product, typically with a strongest band for the fully extended product (see Figure 4 ). Another band may be visible for unextended primer, although in many experiments we do not see this peak ( Figure 4A ), as our primer (Table  1) tends to be efficiently extended. In the second, ligated sample, check that this pattern of peaks has shifted to longer lengths (later elution times) after ligation ( Figure 4B) . In principle this ligation should be quantitative but this is not always the case, and the fraction ligated should be estimated (see Note 7). 2. Subtract the baseline from the data contained in d and store it in a matrix called d_bsub: d_bsub = baseline_subtract_v2(d); 3. Plot the baseline-subtracted data:
Ligation of the Second Illumina Adapter
figure(5) % This creates a new figure window within MATLAB in which to plot the data. plot(d_bsub(:,2)) Here, it is assumed that the second column of d_bsub corresponds to the ligated sample. Use this plot to identify the bounds on the time axis for the shorter oligo peak, the longer oligo peak, and the fully-ligated cDNA region. Record these values as shorter_lower, shorter_upper, longer_lower, longer_upper, cdna_lower, and cdna_upper. 4. Calculate the area of the peaks in the cDNA region by summation: cdna_area = sum(d_sub(cdna_lower:cdna_upper,2)) 5. Calculate the area of the peak for the shorter oligo: shorter = sum(d_bsub(shorter_lower:shorter_upper,2)) 6. Calculate the area of the peak for the longer oligo: longer = sum(d_bsub(longer_lower:longer_upper,2)) 7. Calculate the number of fmols in the 15 µL of sample that can be loaded on the Illumina platform (See Note 9) fmols = 24 * cdna_area / (shorter + longer)
Final Preparation for Sequencing on a MiSeq 1. These instructions, especially the amounts of cDNA loaded, are specific for running on a MiSeq using Illumina's version 2 kits. If an alternative platform is used, this protocol will need to be appropriately adjusted. Place a MiSeq version 2 reagent kit in a pool of water as deep as the fill line on the kit to thaw. Place the HT1 buffer vial in the kit on the bench top to thaw, then keep on ice. 2. The target is to load 30 fmol of cDNA onto the MiSeq plus 5 fmol of the PhiX genome as a positive control. Thirty divided by the number of pools of samples is the number of femtomoles taken from each pool. Given the quantifications of the number of femtomoles in each pool calculated above, calculate the volume of sample needed to be taken from each pool and contributed to the final pool that will be used for sequencing. 3. If the yield of cDNA from a pool is high, such that the volume of sample to be taken from the pool is less than 0.5 μL in order for it to provide its amount of cDNA, then first take a small aliquot of beads and add EB buffer to dilute down such that the target number of femtomoles will be in a 0.5 to 4.5 μL volume. 4. If the yield of cDNA from a pool is low, such that the volume of the library needed to get the desired amount of cDNA is in excess of 4.5 μL, put the pool in a well on a 96-well plate, and place the plate on a magnetic stand. Wait 1-2 minutes for the beads to collect. Discard the supernatant. Remove the plate from the stand. Resuspend the beads in the desired volume of EB buffer. Our experiments have show that the beads do not release a significant amount of cDNA into the supernatant when resuspended in water at the end of the ligation stage. Instead, NaOH is necessary to denature the DNA and release it from the beads (see steps 7 and 8 below). 5. If the volume of the final combined pool of the cDNA library is less than 4.5 μL, add EB buffer such that the final volume equals 4.5 μL. The RNA can be of arbitrary length as each sequence is identified by its 3´ RID (Fig. 1) during the first read on Illumina's 50-cycle kits. The first read must be long enough to read through the primer's PID, the 20nucleotide RNA binding site (RBS), and then through enough nucleotides of the RID region to distinguish the sequence from any other in the pool. Our RNAs typically have RID regions of 8-15 nucleotides. Such an RNA pool would require a first read length of 47 nucleotides. The second read must be long enough to uniquely identify the position of the reverse transcription stop compared to any other position in the RNA. We typically use 20-30 nucleotides, although this may vary depending on the sequence of the RNA. If RNAs in the pool contain long repetitive sequences, the second read will need to be longer so as to extend into the non-repetitive regions (The 50 cycle kit can, when used in the manner of this protocol, be used to read 76 nucleotides, summed over the first and second read.) Illumina's kits include read allotments for indexing above and beyond the stated read lengths that we do not use -we use the barcoding and identification schemes described here instead.
MAPseeker analysis
1. The MAPseeker package is freely available for download at: https://simtk.org/home/map_seeker. Follow the instructions in the README to install on a Mac or other Unix-based machine. 2. Prepare two text files in FASTA format, with a label for each sequence on one line preceded by a ">" character, and the sequence following on the next line. The first FASTA file ("RNA_sequences.fasta") should contain the full-length sequences of every RNA in the run. The second ("primers.fasta") should contain the full sequence of every reverse transcription primer used in the run. 3. The MAPseeker executable takes input in the following format:
$ MAPseeker -1 read1.fastq -2 read2.fastq -l RNA_sequences.fasta -p primers.fasta -n 8
The files read1.fastq and read2.fastq are the FASTQ format sequence files from the MiSeq. The two .fasta files are those prepared in step 1. The flag "-n" specifies the length of the RID region of the RNA (8, in this example). 4. As output, MAPseeker gives summary statistics: the numbers of sequences found in the FASTQ files, the number in which the RNA binding site was found, the number that contained a primer ID that was specified in primers.fasta, and the number of sequences from read 1 and read 2 that matched an RNA sequence specified in RNA_sequences.fasta. It also gives text files named stats_ID1.txt through stats_IDN.txt, where N is the number of primers listed in primers.fasta (stats_ID1.txt corresponds to the first primer in primers.fasta, etc.). The text files contain tab-separated matrices of numbers. Each row corresponds to an RNA as they were listed in the RNA_sequences.fasta file. Each column corresponds to the site where reverse transcription stopped, beginning at 0 (full extension of the RT primer back to the RNA 5´ end) and ending at the 3´ end. Stops in the RID region as specified by "-n" above will all be zero, as they cannot be attributed conclusively to any one RNA. The values correspond to the number of clusters from the sequencing run of the particular RNA that stopped at that position. 5. The data in these text files are tab-delimited, so they are amenable to analysis with a most visualization or plotting programs, or to be further processed with custom analysis scripts. MAPseeker includes scripts in MATLAB (located in the src/matlab/ subdirectory) for quick data analysis and visualization. This protocol will describe the use of these MATLAB scripts. For ease of use, add the map-seeker/src/matlab/ directory to your MATLAB path, and set the present working directory to the directory containing the stats_IDN.txt files as well as the two input FASTA files. Run from within MATLAB: AMPure XP beads should not be mixed with the modification reagents for longer than the times prescribed in this protocol. The reagents and quenches may damage them and ruin the purification. If the beads turn from brown to green, then the purification has likely failed. 3. Illumina's MiSeq platform requires that the first 12 reads made by the sequencer are "sequence-balanced," namely, that there are approximately an equal number of A's, C's, G's, and T's read across all the clusters. This is not much of a problem for genomic DNA, but the cDNA libraries described here all begin with the same 20-nucleotide primer binding site, which would ruin the sequence balancing. So, immediately upstream of the primer region is a 12-nucleotide sequence-balancing region. We also use this region as a unique primer identifier (PID) for which chemical modification reaction a given cluster came from. Primers must be made and used in sets of four; within each set of four, one primer must have an A at the first position, another must have a C at the first position, etc. Our sequences ( Table 1) were designed to minimize secondary structure with the primer region (as assessed with NUPACK) (38) while maintaining sequence balance and disallowing 4 or more Gs in a row in any primer. 4. The loading control sequences we use are in Table 1 . We had these sequences on hand for other applications. Other sequences should work just as well, as long as their lengths are less than the reverse transcription primers used above, so that their signals appear at locations distinct from the library in the capillary electrophoretic trace. Note that at low 1 nM concentration, these oligos may stick to the sides of conventional 1.5 mL tubes, lowering the accuracy of the control over time; use of non-stick tubes and storage of stocks at concentrations greater than 100 nM are recommended. 5. Only one site of modification can be identified by reverse transcription, so it is important to choose reaction conditions that modify each RNA once or not at all. Longer RNAs have more sites that can be modified, so it is important to lower reaction times and/or concentrations of reagents. 6. Ethanol is strong inhibitor of reverse transcription and ligation. It needs to be completely removed by pipetting and evaporation, with no remaining liquid visible and with the beads appearing dried out. 7. The factor of 24 comes from the fact that the number of femtomoles of sample being read by the sequencer is 1/8 of the amount of primer used in the transcription, and the remaining sample is 1.5 times larger than the aliquot used in the quantification. The final factor of two comes from averaging the areas of the smaller and larger oligo peaks, by which the area under the library peaks is divided. 8. Using CircLigase (i.e., TS2126 thermostable RNA ligase), we typically observe that the ligation of the adapter to reverse transcription products is near quantitative (>80%) in a sequence-independent manner, within the detection limits of capillary electrophoresis. The one exception is that the fully extended product is ligated with poorer efficiency (~50%; Figure 4A and 4B); it is not yet clear if this is due to a sequence bias (our transcripts begin with GG, leaving CC at the 3´ ends of these cDNA primer extension products) or to addition of some ligation-blocking modification by SuperScript III reverse transcriptase on cDNA that has completely extended to the end of an RNA. In any case, if the ligation efficiency of the full product is known, it can be specified at the time of data analysis and correction as a fourth argument in quick_look_MAPseeker. The default correction factor is 2.0; changing this number will affect the overall scale of the final reactivities and, less sensitively, the correction for attenuation which reweights the balance of short and long reverse transcription products [equation (1)]. 9. Accurate quantification of the cDNA library is critical for acquiring high-quality sequencing data. Loading too much sample will ruin the results due to too many overlapping clusters of DNA that cannot be distinguished from one another by the sequencer, and loading too little may not yield enough clusters for the Illumina platform to find the flow cell during initial auto-focus stages. Also note that double-stranded DNA, such as the PhiX genomic DNA we recommend to be co-loaded with the singlestranded cDNA library, produces twice as many clusters per mole as single-stranded cDNA. 10. While it is possible to design a protocol that could conceivably discard less material than this one, the volumes involved for the early steps may be so small, depending on the yield after ligation, that it would typically be necessary to dilute down some of the pools of beads after ligation, and then end up discarding the leftover anyway. 11. The 625 μL of solution left over after this step should be discarded, unless it is going to be used in a parallel MiSeq sequencing run on the same day. Our experience is that the solution is not useable for additional runs even if stored overnight at 4 ºC. Figure 1 . Overview of the MAP-seq experimental protocol. Each RNA has a primer binding site at its 3´ end (PBS), preceded by an RNA ID (RID) unique to each sequence, which we usually sequester into a hairpin (Table 1) . First, the RNA is subject to modification by a chosen chemical reagent. The site of modification is denoted with an asterisk. Second, the RNA is reverse transcribed using a primer that has at its 3´ end an RNA binding site (RBS) complementary to the primer binding site (PBS). The primer contains a sequence-balanced 12-nucleotide primer identification region (PID), and segments necessary for sequencing read 1 and bridge amplification in the Illumina flow cell. Third, the second Illumina adapter containing the read 2 PBS, and the other DNA necessary for bridge amplification is ligated to the 3´ end of each cDNA with a single-stranded DNA ligase. Additional sequence segments within the Illumina adapters (gray) can be used for further multiplexing of experimental conditions, but are not used in the current protocol. Figure 2 ). Error bars for the MAP-seq data were estimated from statistical error on the number of reads (smaller than the line width at most sequences), as carried out by MAPseeker analysis. Error bars for the CE data were estimated after HiTRACE quantitation (36) as the standard deviation across five measurements using 1M7 concentrations of 0.625, 1.25, 2.5, 5, and 10.0 mg/mL, and an additional two replicates in the 10 mg/mL condition. Two regions that show discrepancy between the CE and MAP-seq data beyond this error are highlighted with stars; both cases can be traced to band compression in the CE experiments (not shown), which introduces systematic uncertainty in band deconvolution near guanosine residues. A .
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